Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
VRTX Vertex Pharmaceuticals Incorporated monthly Stock Chart
VRTX [NASD]
Vertex Pharmaceuticals Incorporated
Healthcare | Biotechnology | USA
statements
IndexS&P 500 P/E26.16 EPS (ttm)7.91 Insider Own0.10% Shs Outstand260.47M Perf Week-1.46%
Market Cap53.54B Forward P/E18.38 EPS next Y11.26 Insider Trans-65.03% Shs Float260.09M Perf Month-23.93%
Income2.08B PEG1.07 EPS next Q2.34 Inst Own96.60% Short Float1.30% Perf Quarter-23.89%
Sales5.40B P/S9.91 EPS this Y118.10% Inst Trans0.65% Short Ratio1.97 Perf Half Y-18.79%
Book/sh28.96 P/B7.15 EPS next Y14.49% ROA23.80% Target Price306.09 Perf Year3.88%
Cash/sh21.08 P/C9.82 EPS next 5Y24.55% ROE32.90% 52W Range193.26 - 306.08 Perf YTD-5.45%
Dividend- P/FCF20.94 EPS past 5Y28.00% ROI14.70% 52W High-32.37% Beta0.66
Dividend %- Quick Ratio3.60 Sales past 5Y48.30% Gross Margin87.70% 52W Low7.11% ATR8.62
Employees3000 Current Ratio3.70 Sales Q/Q62.00% Oper. Margin38.70% RSI (14)28.37 Volatility2.74% 3.19%
OptionableYes Debt/Eq0.00 EPS Q/Q208.80% Profit Margin38.50% Rel Volume1.11 Prev Close208.34
ShortableYes LT Debt/Eq0.07 EarningsOct 29 AMC Payout0.00% Avg Volume1.72M Price207.01
Recom2.00 SMA20-14.10% SMA50-19.56% SMA200-19.99% Volume1,915,211 Change-0.64%
Oct-28-20Initiated UBS Buy $287
Jul-31-20Reiterated H.C. Wainwright Buy $295 → $315
Jul-08-20Downgrade Morgan Stanley Overweight → Equal-Weight $300
Apr-30-20Reiterated H.C. Wainwright Buy $270 → $295
Apr-28-20Downgrade RBC Capital Mkts Outperform → Sector Perform $250 → $260
Mar-04-20Initiated Barclays Overweight $271
Jan-31-20Downgrade Robert W. Baird Outperform → Neutral $210 → $230
Nov-19-19Upgrade Guggenheim Neutral → Buy $252
Nov-12-19Initiated SunTrust Buy $235
Oct-17-19Resumed BofA/Merrill Buy $220
Sep-03-19Upgrade Goldman Neutral → Buy $226 → $254
Aug-01-19Downgrade Needham Buy → Hold
May-23-19Resumed Citigroup Buy $205
May-21-19Initiated Credit Suisse Outperform $209
Apr-12-19Initiated Evercore ISI In-line
Mar-26-19Upgrade William Blair Mkt Perform → Outperform
Mar-19-19Downgrade SVB Leerink Outperform → Mkt Perform
Feb-06-19Downgrade Maxim Group Buy → Hold
Jan-02-19Downgrade Raymond James Outperform → Mkt Perform
Oct-26-18Upgrade H.C. Wainwright Neutral → Buy $220
Oct-29-20 05:35PM  
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates
Zacks
04:52PM  
Recap: Vertex Pharmaceuticals Q3 Earnings
Benzinga
04:01PM  
Vertex Reports Third-Quarter 2020 Financial Results
Business Wire
02:30PM  
Vertex Pharmaceuticals, Inc.to Host Earnings Call
ACCESSWIRE
Oct-28-20 12:55PM  
What's in Store for ADMA Biologics' (ADMA) Q3 Earnings?
Zacks
12:38PM  
Benzinga's Top Upgrades, Downgrades For October 28, 2020
Benzinga
07:00AM  
Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals
Motley Fool
Oct-27-20 11:29AM  
Moderna (MRNA) to Report Q3 Earnings: What's in the Cards?
Zacks
10:08AM  
3 Biotech Stocks I'd Buy Right Now
Motley Fool
Oct-26-20 01:06PM  
Mattel, PLCE, Gilead, Vertex and Horizon as Zacks Bull and Bear of the Day
Zacks
12:52PM  
Were These Hedge Funds Right About Selling Vertex Pharmaceuticals Incorporated (VRTX)?
Insider Monkey
09:19AM  
What's in the Cards for Cassava (SAVA) This Earnings Season?
Zacks
08:45AM  
Can Trikafta Drive Vertex's (VRTX) Revenues in Q3 Earnings?
Zacks
08:00AM  
Best ESG Companies By Category: These Are The Top 3 ESG Stocks In 8 Industries
Investor's Business Daily
08:00AM  
Best ESG Companies: Top 50 Stocks For Environmental, Social And Governance Values
Investor's Business Daily
Oct-23-20 07:42AM  
Will Coronavirus Woes Affect Gilead's (GILD) Q3 Earnings?
Zacks
Oct-22-20 01:19PM  
Fastest-Growing Companies: 24 Stocks Expecting Up To 603% Growth In 2020
Investor's Business Daily
12:34PM  
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
11:22AM  
Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates
Zacks
Oct-21-20 10:46AM  
AstraZeneca's (AZN) Tagrisso sNDA Receives Priority Review
Zacks
09:03AM  
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
Zacks
08:55AM  
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co
Zacks
Oct-20-20 11:30AM  
Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?
Zacks
10:40AM  
Endo (ENDP) Gains on Deal to Acquire BioSpecifics for $540M
Zacks
09:26AM  
Pick These 5 Stocks With Superb Interest Coverage Ratio
Zacks
07:39AM  
Vertex Pharmaceuticals (VRTX) Enters Oversold Territory
Zacks
Oct-19-20 05:50PM  
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
Zacks
04:01PM  
Vertex to Announce Third-Quarter 2020 Financial Results on October 29
Business Wire
Oct-16-20 04:34PM  
Stock Market Rally Pauses Amid Stalled Stimulus; Apple iPhone, Amazon Prime Day In Focus, Fastly, Vertex Plunge
Investor's Business Daily
01:05PM  
Lilly to Acquire Private Biotech for Boosting Pain Portfolio
Zacks
11:16AM  
Vertex (VRTX) Drops 20% After Failed Drug Trial
Investopedia
09:43AM  
Stock Market News for Oct 16, 2020
Zacks
07:04AM  
Forget Snowflake! 2 Hyper-Growth Stocks I'd Rather Buy
Motley Fool
Oct-15-20 07:47PM  
Tech Wrecks S&P 500: Most Stocks Gain Today, but Facebook, Other Tech Giants Crash the Party
Motley Fool -20.70%
05:44PM  
Dow Jones Futures: Zoom Video Flags Another Breakout; Market Pause Bullish For Apple, These Titans
Investor's Business Daily
05:00PM  
Why Arrowhead Pharmaceuticals Stock Jumped Today
Motley Fool
04:12PM  
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
Investor's Business Daily
03:12PM  
Vertex Pulls Nasdaq Down, but Wall Street Loves Zoom
Motley Fool
01:37PM  
Dow Jones Extends Losses On Unemployment Claims; Two Growth Stocks Rise
Investor's Business Daily
12:17PM  
Dow Jones Trims Losses After Taking A Steep Dive On Jobless Claims Spike
Investor's Business Daily
11:54AM  
If You Had Bought Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Five Years Ago, You Could Pocket A 148% Gain Today
Simply Wall St.
10:17AM  
P/E Ratio Insights for Vertex Pharmaceuticals
Benzinga
09:59AM  
Dow Jones Today, Stocks Chase Overseas Losses As Jobless Claims Surge; Sleep Number, Arrowhead Spike
Investor's Business Daily
09:51AM  
Why Vertex Pharmaceuticals Stock Is Slumping Today
Motley Fool
09:29AM  
Vertex Pharma Off After Analysts Comment on Drug-Trial Halt
TheStreet.com
08:13AM  
Dow Jones Futures Fall: Fastly, Vertex Crash, Tesla Tests Buy Point As Stimulus Deal Doubts Hit Stock Market Rally
Investor's Business Daily
08:03AM  
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
Benzinga
07:31AM  
Analysts say Vertex's stock is under pressure after drug development failure
MarketWatch
04:12AM  
Vertex Sinks 12% On Halt of VX-814 Development; Merrill Lynch Says Buy
SmarterAnalyst
Oct-14-20 06:49PM  
Dow Jones Futures: Stimulus Deal Doubts Pause Stock Market Rally; Tesla Leads EV Breakouts; Fastly, Vertex Dive Late
Investor's Business Daily
05:19PM  
13 Stocks Moving In Wednesday's After-Hours Session
Benzinga
04:30PM  
Vertex Provides Update on its Clinical Programs Targeting Alpha-1 Antitrypsin Deficiency
Business Wire
12:10PM  
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?
Zacks
06:06AM  
4 Growth Stocks You Can Safely Hold Through 2030
Motley Fool
Oct-13-20 05:50PM  
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
Zacks
09:45AM  
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher
Zacks
Oct-12-20 09:45AM  
Booming Gene Editing Market to Pep Up These 5 Biotech Stocks
Zacks
Oct-09-20 06:10AM  
Investing $1,000 in These 3 Stocks Would Be a Really Smart Move Right Now
Motley Fool
Oct-07-20 05:50PM  
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Zacks
10:46AM  
Corbus Stock Down as Lenabasum Fails to Meet Primary Endpoint
Zacks
05:51AM  
Got $1,000? 3 Stocks to Buy if the Market Crashes
Motley Fool
Oct-06-20 09:01AM  
Add These 5 Stocks With Impressive Interest Coverage Ratio
Zacks
Oct-04-20 07:32AM  
3 Top Stocks to Buy in October
Motley Fool
07:15AM  
What You Need to Know About Orphan Drug Designations
Motley Fool
06:20AM  
2 Top Biotech Stocks to Buy in October
Motley Fool
Oct-03-20 07:38AM  
Where Will Vertex Pharmaceuticals Be in 5 Years?
Motley Fool
Oct-02-20 05:48AM  
What's Next for Stocks
Kiplinger
Sep-30-20 11:30AM  
Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?
Zacks
Sep-29-20 05:50PM  
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
Zacks
Sep-28-20 12:35PM  
Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants
Zacks
Sep-27-20 05:52AM  
Vertex or Galapagos: Which Biotech Stock Does The Street Favor?
SmarterAnalyst
Sep-25-20 08:00AM  
FDA Approves KALYDECO® (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants With CF as Early as Four Months of Age
Business Wire
Sep-24-20 05:25AM  
Vertex to Present New Data at European and North American Virtual Cystic Fibrosis Conferences Highlighting Long-Term Use of CFTR Modulators
Business Wire
Sep-23-20 11:03AM  
CRISPR Therapeutics Gene Therapy CTX001 Gets PRIME Status
Zacks
07:07AM  
Stock Market Crash 2.0: Where to Invest $1,000
Motley Fool
Sep-22-20 09:00AM  
CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001 for the Treatment of Sickle Cell Disease
GlobeNewswire
Sep-21-20 05:50PM  
Vertex Pharmaceuticals (VRTX) Stock Moves -0.52%: What You Should Know
Zacks
Sep-18-20 09:32PM  
Why One Analyst Thinks That Dell Is Undervalued
Barrons.com
Sep-17-20 08:03PM  
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy
Motley Fool
06:54PM  
Why Moderna Was So Volatile on Thursday
Motley Fool
05:23PM  
Moderna Shares the Latest on its Coronavirus Vaccine Trial and Other Research Advances
Barrons.com
04:16PM  
Moderna Updates Progress On Covid-19 Vaccine, Eyes Flu Vaccine
Investor's Business Daily
09:12AM  
Moderna Stock Rises 3% On Vertex Deal
SmarterAnalyst
06:16AM  
Stock Market Crash 2.0: Here Are 3 Stocks You'll Absolutely, Positively Want to Buy
Motley Fool
Sep-16-20 04:33PM  
3 Nasdaq Stocks to Buy Off Their Corrective Bottoms
InvestorPlace
04:30PM  
Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene Editing
Business Wire
Sep-15-20 10:13AM  
Vertex Eyes Label Expansion of Triple Combo CF Drug in Europe
Zacks
Sep-14-20 04:15AM  
Vertex Announces European Medicines Agency Type II Variation Marketing Authorization Application Validation for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination with ivacaftor in People with One Copy of the F508del Mutation
Business Wire
Sep-13-20 06:52AM  
Got $5,000? 3 Surefire Stocks to Buy Ahead of the Next Market Crash
Motley Fool
Sep-11-20 05:50PM  
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Zacks
06:08AM  
3 Incredibly Strong Stocks to Buy That Should Thrive Even If the Stock Market Crashes Again
Motley Fool
Sep-10-20 03:32PM  
Vertex Pharmaceuticals Reports Positive Phase 3 Results in Children for Blockbuster CF Drug
Motley Fool
09:00AM  
Vertex Announces Positive Phase 3 Study for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children Ages 6-11 Years With Cystic Fibrosis to Support Submissions for Global Regulatory Approvals
Business Wire
06:55AM  
2 Game-Changing Biotech Stocks That May Make You Rich
Motley Fool
03:57AM  
The Vertex Foundation Announces 1 Million Donation to Ronald McDonald House Charities at the New Childrens Hospital in Ireland
Business Wire
Sep-09-20 07:15AM  
Could Vertex Pharmaceuticals Be a Millionaire-Maker Stock?
Motley Fool
Sep-07-20 07:30AM  
Is Vertex Pharmaceuticals Stock a Buy?
Motley Fool
Sep-04-20 09:15AM  
Next Coronavirus Market Crash: Where to Invest $1,000
Motley Fool
08:00AM  
Where to Invest $10,000 Right Now
Motley Fool
06:11AM  
Got $3,000? Buying These 3 Stocks Could Make You Rich
Motley Fool
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhatia Sangeeta N.DirectorOct 05Option Exercise126.688,7291,105,79014,424Oct 07 04:11 PM
Bhatia Sangeeta N.DirectorOct 05Sale266.7910,5162,805,5183,908Oct 07 04:11 PM
Silva Paul MSVP & ControllerAug 06Option Exercise169.391,078182,59816,010Aug 10 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 06Option Exercise155.571,223190,26230,125Aug 10 04:13 PM
Kewalramani ReshmaCEO & PresidentAug 06Option Exercise179.682,073372,48228,699Aug 10 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 06Option Exercise155.571,223190,26228,061Aug 10 04:22 PM
Silva Paul MSVP & ControllerAug 06Sale271.171,078292,31914,932Aug 10 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 06Sale271.191,223331,66328,902Aug 10 04:13 PM
Kewalramani ReshmaCEO & PresidentAug 06Sale271.202,073562,20526,626Aug 10 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 06Sale271.201,223331,67226,838Aug 10 04:22 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 03Option Exercise86.522,330201,59231,232Aug 05 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerAug 03Option Exercise86.521,553134,36636,732Aug 05 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 03Option Exercise86.522,330201,59229,168Aug 05 04:20 PM
Silva Paul MSVP & ControllerAug 03Option Exercise86.5280969,99515,741Aug 05 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerAug 03Option Exercise86.521,941167,93537,044Aug 05 04:51 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 03Sale278.242,330648,29028,902Aug 05 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerAug 03Sale278.391,553432,33735,179Aug 05 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 03Sale278.282,330648,40226,838Aug 05 04:20 PM
Silva Paul MSVP & ControllerAug 03Sale278.30809225,14214,932Aug 05 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerAug 03Sale278.281,941540,13735,103Aug 05 04:51 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffJul 13Option Exercise90.292,125191,86628,963Jul 15 04:41 PM
Silva Paul MSVP & ControllerJul 13Option Exercise90.2986077,64915,792Jul 15 04:51 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffJul 13Sale292.052,125620,61026,838Jul 15 04:41 PM
Silva Paul MSVP & ControllerJul 13Sale292.03860251,14514,932Jul 15 04:51 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJul 10Sale293.15700205,20616,126Jul 14 04:16 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJul 07Option Exercise173.512,786483,40337,965Jul 09 04:13 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJul 07Sale300.002,786835,80035,179Jul 09 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanJun 30Sale286.1532,7929,383,3042,261Jul 02 04:15 PM
Bhatia Sangeeta N.DirectorJun 02Sale282.88952269,2985,695Jun 03 04:22 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 15Sale284.378223,31828,902May 19 04:21 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerMay 15Sale283.9811332,08935,179May 19 04:22 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 15Sale284.406819,33926,838May 19 04:28 PM
Sachdev AmitEVP, Chief Patient OfficerMay 15Sale284.415816,49635,103May 19 04:29 PM
Silva Paul MSVP & ControllerMay 15Sale284.0015142,88514,932May 19 04:31 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 15Sale284.0012034,08012,738May 19 04:33 PM
Kewalramani ReshmaCEO & PresidentMay 15Sale284.179928,13226,626May 19 04:35 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 12Option Exercise187.531,304244,53930,206May 14 04:17 PM
LEIDEN JEFFREY MExecutive ChairmanMay 12Option Exercise137.5288,53212,174,639129,353May 14 04:19 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 12Sale287.331,304374,67828,902May 14 04:17 PM
LEIDEN JEFFREY MExecutive ChairmanMay 12Sale283.4794,37026,751,44034,983May 14 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 11Option Exercise187.531,304244,53928,142May 13 04:18 PM
Sachdev AmitEVP, Chief Patient OfficerMay 11Option Exercise131.8910,6651,406,60745,768May 13 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 11Sale286.001,304372,94426,838May 13 04:18 PM
Sachdev AmitEVP, Chief Patient OfficerMay 11Sale282.6110,6653,014,01435,103May 13 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanMay 07Option Exercise137.5288,53412,174,982135,190May 08 04:20 PM
SACHS BRUCE IDirectorMay 07Option Exercise70.5545,0003,174,52556,210May 08 04:24 PM
LEIDEN JEFFREY MExecutive ChairmanMay 07Sale269.7894,36925,459,01340,821May 08 04:20 PM
SACHS BRUCE IDirectorMay 07Sale269.8045,00012,140,80611,210May 08 04:24 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 06Option Exercise174.06966168,14613,704May 08 04:28 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 06Option Exercise155.571,222190,10730,124May 08 04:17 PM
Kewalramani ReshmaCEO & PresidentMay 06Option Exercise179.672,074372,63828,700May 08 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 06Option Exercise155.571,222190,10728,060May 08 04:22 PM
Sachdev AmitEVP, Chief Patient OfficerMay 06Option Exercise131.8966988,23435,772May 08 04:23 PM
Silva Paul MSVP & ControllerMay 06Option Exercise169.381,076182,25516,008May 08 04:26 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 06Sale272.70966263,43112,738May 08 04:28 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 06Sale272.661,222333,19528,902May 08 04:17 PM
Kewalramani ReshmaCEO & PresidentMay 06Sale272.852,074565,88226,626May 08 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 06Sale272.641,222333,16526,838May 08 04:22 PM
Sachdev AmitEVP, Chief Patient OfficerMay 06Sale275.28669184,16235,103May 08 04:23 PM
Silva Paul MSVP & ControllerMay 06Sale272.741,076293,47214,932May 08 04:26 PM
Sachdev AmitEVP, Chief Patient OfficerMay 05Option Exercise131.8913,3561,761,52348,459May 06 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Option Exercise137.5288,53712,175,273141,028May 07 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerMay 05Sale270.0113,3563,606,23235,103May 06 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Sale269.9494,37225,475,03746,656May 07 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 04Option Exercise86.522,330201,59231,232May 06 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 04Option Exercise86.522,330201,59229,168May 06 04:25 PM
Silva Paul MSVP & ControllerMay 04Option Exercise86.5280969,99515,741May 06 04:27 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerMay 04Option Exercise86.521,553134,36636,732May 06 04:38 PM
Sachdev AmitEVP, Chief Patient OfficerMay 04Option Exercise112.9843,7524,942,96878,855May 06 04:43 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 04Sale260.862,330607,80328,902May 06 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 04Sale260.872,330607,82726,838May 06 04:25 PM
Silva Paul MSVP & ControllerMay 04Sale260.87809211,04814,932May 06 04:27 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerMay 04Sale260.761,553404,95735,179May 06 04:38 PM
Sachdev AmitEVP, Chief Patient OfficerMay 04Sale262.2843,75211,475,17935,103May 06 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffApr 29Option Exercise90.292,125191,86628,963May 01 04:22 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffApr 29Sale254.952,125541,76926,838May 01 04:22 PM
Lee YuchunDirectorApr 28Option Exercise57.271,12564,4293,000Apr 29 04:14 PM
Lee YuchunDirectorApr 28Sale257.881,125290,1151,875Apr 29 04:14 PM
Lee YuchunDirectorApr 27Option Exercise57.272,000114,5403,875Apr 28 04:23 PM
Lee YuchunDirectorApr 27Sale271.212,000542,4191,875Apr 28 04:23 PM
Lee YuchunDirectorApr 24Option Exercise57.272,000114,5403,875Apr 28 04:23 PM
Lee YuchunDirectorApr 24Sale268.142,000536,2861,875Apr 28 04:23 PM
Lee YuchunDirectorApr 23Option Exercise57.272,000114,5403,875Apr 24 04:17 PM
Lee YuchunDirectorApr 23Sale272.532,000545,0521,875Apr 24 04:17 PM
Lee YuchunDirectorApr 22Option Exercise57.272,000114,5403,875Apr 24 04:17 PM
Lee YuchunDirectorApr 22Sale267.882,000535,7531,875Apr 24 04:17 PM
Lee YuchunDirectorApr 21Option Exercise57.272,000114,5403,875Apr 22 04:14 PM
Lee YuchunDirectorApr 21Sale266.762,000533,5231,875Apr 22 04:14 PM
Lee YuchunDirectorApr 20Option Exercise57.272,000114,5403,875Apr 22 04:14 PM
Lee YuchunDirectorApr 20Sale273.162,000546,3101,875Apr 22 04:14 PM
Silva Paul MSVP & ControllerApr 13Option Exercise90.2985977,55915,791Apr 15 04:15 PM
Silva Paul MSVP & ControllerApr 13Sale248.72859213,65014,932Apr 15 04:15 PM
Silva Paul MSVP & ControllerApr 06Option Exercise155.574,891760,89319,823Apr 08 04:17 PM
Silva Paul MSVP & ControllerApr 06Sale255.574,8911,249,99314,932Apr 08 04:17 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 25Sale233.413,028706,77628,902Feb 26 04:29 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 25Sale233.743,634849,41835,179Feb 26 04:30 PM
Kewalramani ReshmaEVP and CMOFeb 25Sale233.453,634848,37126,626Feb 26 04:32 PM
LEIDEN JEFFREY MCEO & PresidentFeb 25Sale233.4610,5502,463,04692,581Feb 26 04:34 PM
Parini MichaelEVP, CL&AOFeb 25Sale233.493,028707,00526,838Feb 26 04:35 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 25Sale233.533,376788,40232,915Feb 26 04:36 PM
open in yahoo | open in reuters | open in google
affiliate | advertise | contact | privacy | help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.